Oxford Bioscience Partners II Overview

  • Fund Type
  • Venture

  • Fund Status
  • Liquidated

  • Size

  • Vintage
  • 1996

Vintage

  • Dry Powder

Oxford Bioscience Partners II General Information

Description

Oxford Bioscience Partners II was a venture capital fund managed by Oxford Bioscience Partners. The fund was located in Mansfield, Massachusetts. The fund targeted to invest in the pharmaceutical, biotechnology and life science sectors.

Contact Information

Fund Manager Website
Fund Category
Venture Capital
Fund Family
Oxford Bioscience Partners
Native Currency
USD
Fund Manager's Location
  • P.O. Box 207
  • 12 Giles Place
  • Mansfield, MA 02048
  • United States
Fund Domiciles
United States

Oxford Bioscience Partners II Investments (37)

Oxford Bioscience Partners II has made a total of 37 investments. Its most recent deal was a with Inkine Pharmaceuticals for . The deal was made on 12-Feb-2003.

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Inkine Pharmaceuticals 12-Feb-2003 Pharmaceuticals Generating Revenue
Psychiatric Genomics 19-Nov-2002 Drug Discovery Startup
Artesian Therapeutics 22-Sep-2002 Pharmaceuticals Product Development
Scion Pharmaceuticals 29-Jul-2002 Drug Discovery Clinical Trials - Phase 1
Zone Labs 07-Jun-2002 Network Management Software Generating Revenue
Memory Pharmaceuticals 25-Mar-2002 Pharmaceuticals Generating Revenue
ArgoMed 07-Feb-2002 Biotechnology Generating Revenue
Avalon Pharmaceuticals 17-Dec-2001 Biotechnology Generating Revenue
Astex Therapeutics 17-Dec-2001 Early Stage VC Drug Discovery Product Development
Eurobio Scientific 05-Dec-2001 Early Stage VC Biotechnology Generating Revenue
You’re viewing 10 of 37 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Oxford Bioscience Partners II Investment Strategy

Investments by Industry

Investments by Deal Type

PitchBook helps you see a fund’s investments based on target industry, year and deal type—so you can quickly understand its strategy at a glance.

Request a free trial

Oxford Bioscience Partners II Limited Partners (9)

United of Omaha Life Insurance Company is one of Oxford Bioscience Partners II’s 9 limited partners. Its latest Original was on 06-Nov-1996.

Limited Partner Name Type Status Commitment Date Commitment Type
United of Omaha Life Insurance Company Current 06-Nov-1996 Original
Alfred University Current 01-Jan-1996 Original
BP Master Trust For Employee Pension Plans Current 01-Jan-1996 Original
DeA Capital Current 01-Jan-1996 Original
DeA Capital Fund of Funds Current 01-Jan-1996 Secondary
You’re viewing 5 of 9 limited partners. Get the full list »

Oxford Bioscience Partners II Returns Data

The below charts are illustrative of the type of graphical data available to our clients and do not represent live data.

IRR (%)

 

DPI (x)

 

RVPI (x)

 

TVPI (x)

 

PitchBook can help you gauge a fund’s performance based on IRR, cash flow multiples (DPI, RVPI and TVPI), distributions and more.

Request a free trial

Oxford Bioscience Partners II Returns History

Period Contribution (by all LPs) Dry Powder Distribution (to all LPs) NAV Total Fund Distr+NAV IRR DPI RVPI TVPI Dry Powder %

This information is available in the PitchBook Platform. To explore Oxford Bioscience Partners II‘s full profile, request access.

Request a free trial

Oxford Bioscience Partners II FAQs

  • What is Oxford Bioscience Partners II?

    Oxford Bioscience Partners II was a venture capital fund managed by Oxford Bioscience Partners.

  • Who manages Oxford Bioscience Partners II?

    Oxford Bioscience Partners II is managed by Oxford Bioscience Partners.

  • Where is Oxford Bioscience Partners II domiciled?

    Oxford Bioscience Partners II is domiciled in United States.

  • What is Oxford Bioscience Partners II's size?

    Oxford Bioscience Partners II has a size of .

  • What type of fund is Oxford Bioscience Partners II?

    The fund type of Oxford Bioscience Partners II is Venture.

  • What is the status of Oxford Bioscience Partners II?

    Oxford Bioscience Partners II is liquidated.

  • What has Oxford Bioscience Partners II invested in?

    Oxford Bioscience Partners II has made numerous investments in companies like Inkine Pharmaceuticals, Psychiatric Genomics, and Artesian Therapeutics within the Pharmaceuticals and Drug Discovery industries.

  • What has Oxford Bioscience Partners II invested in recently?

    Oxford Bioscience Partners II's latest investment was on 12-Feb-2003 in Inkine Pharmaceuticals, a company within the Pharmaceuticals industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »